AllianceBernstein
NVAX icon

AllianceBernstein’s Novavax NVAX Stock Holding History

AllianceBernstein’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Sell
160,603
-2,610
-2% -$23.4K ﹤0.01% 2264
2026
Q1 		$1.1M Hold
163,213
– – ﹤0.01% 2306
2025
Q4 		$1.1M Sell
163,213
-157
-0.1% -$1.18K ﹤0.01% 2302
2025
Q3 		$1.42M Buy
163,370
+157
+0.1% +$1.22K ﹤0.01% 2182
2025
Q2 		$1.03M Hold
163,213
– – ﹤0.01% 2272
2025
Q1 		$1.05M Hold
163,213
– – ﹤0.01% 2217
2024
Q4 		$1.31M Hold
163,213
– – ﹤0.01% 2179
2024
Q3 		$2.06M Hold
163,213
– – ﹤0.01% 1953
2024
Q2 		$2.07M Buy
163,213
+51,483
+46% +$518K ﹤0.01% 1930
2024
Q1 		$534K Sell
111,730
-653
-0.6% -$3.03K ﹤0.01% 2560
2023
Q4 		$539K Sell
112,383
-4,692
-4% -$28.7K ﹤0.01% 2571
2023
Q3 		$848K Buy
117,075
+3,299
+3% +$26.4K ﹤0.01% 2328
2023
Q2 		$845K Buy
113,776
+39,589
+53% +$311K ﹤0.01% 2362
2023
Q1 		$514K Buy
74,187
+40,876
+123% +$376K ﹤0.01% 2557
2022
Q4 		$342K Buy
33,311
+14
+0% +$247 ﹤0.01% 2813
2022
Q3 		$606K Sell
33,297
-51,097
-61% -$2.21M ﹤0.01% 2549
2022
Q2 		$4.34M Buy
84,394
+30,216
+56% +$1.57M ﹤0.01% 1523
2022
Q1 		$3.99M Buy
54,178
+19,577
+57% +$1.75M ﹤0.01% 1694
2021
Q4 		$4.95M Sell
34,601
-11,420
-25% -$1.96M ﹤0.01% 1628
2021
Q3 		$9.54M Buy
46,021
+1,593
+4% +$351K ﹤0.01% 1264
2021
Q2 		$9.43M Sell
44,428
-62,061
-58% -$11.4M ﹤0.01% 1264
2021
Q1 		$19.3M Buy
106,489
+19,661
+23% +$3.92M 0.01% 940
2020
Q4 		$9.68M Sell
86,828
-17,762
-17% -$1.89M ﹤0.01% 1149
2020
Q3 		$11.3M Sell
104,590
-2,850
-3% -$347K 0.01% 989
2020
Q2 		$8.96M Buy
107,440
+49,000
+84% +$1.87M 0.01% 1049
2020
Q1 		$794K Buy
58,440
+23,400
+67% +$198K ﹤0.01% 2138
2019
Q4 		$139K Sell
35,040
-282
-0.8% -$1.22K ﹤0.01% 2991
2019
Q3 		$177K Hold
35,322
– – ﹤0.01% 2972
2019
Q2 		$207K Buy
35,322
+23,447
+197% +$185K ﹤0.01% 2954
2019
Q1 		$131K Sell
11,875
-7,625
-39% -$241K ﹤0.01% 2988
2018
Q4 		$718K Buy
19,500
+395
+2% +$15.3K ﹤0.01% 2344
2018
Q3 		$718K Hold
19,105
– – ﹤0.01% 2480
2018
Q2 		$512K Buy
19,105
+2,235
+13% +$75.5K ﹤0.01% 2603
2018
Q1 		$709K Buy
16,870
+4,205
+33% +$169K ﹤0.01% 2407
2017
Q4 		$314K Sell
12,665
-2,865
-18% -$69.9K ﹤0.01% 2700
2017
Q3 		$354K Sell
15,530
-5,755
-27% -$129K ﹤0.01% 2701
2017
Q2 		$490K Buy
21,285
+6,060
+40% +$119K ﹤0.01% 2623
2017
Q1 		$390K Sell
15,225
-2,960
-16% -$81.4K ﹤0.01% 2611
2016
Q4 		$458K Sell
18,185
-3,975
-18% -$116K ﹤0.01% 2593
2016
Q3 		$922K Sell
22,160
-50
-0.2% -$6.46K ﹤0.01% 2261
2016
Q2 		$3.23M Buy
22,210
+50
+0.2% +$5.73K ﹤0.01% 1309
2016
Q1 		$2.29M Hold
22,160
– – ﹤0.01% 1500
2015
Q4 		$3.72M Hold
22,160
– – ﹤0.01% 1194
2015
Q3 		$3.13M Sell
22,160
-28
-0.1% -$6.28K ﹤0.01% 1310
2015
Q2 		$4.94M Buy
22,188
+2,190
+11% +$385K ﹤0.01% 1121
2015
Q1 		$3.31M Buy
19,998
+3,985
+25% +$647K ﹤0.01% 1381
2014
Q4 		$1.9M Hold
16,013
– – ﹤0.01% 1784
2014
Q3 		$1.33M Hold
16,013
– – ﹤0.01% 2011
2014
Q2 		$1.48M Sell
16,013
-10
-0.1% -$879 ﹤0.01% 1996
2014
Q1 		$1.45M Buy
16,023
+2,070
+15% +$231K ﹤0.01% 1933
2013
Q4 		$1.43M Buy
13,953
+7,040
+102% +$497K ﹤0.01% 1947
2013
Q3 		$437K Sell
6,913
-1,634
-19% -$92K ﹤0.01% 2541
2013
Q2 		$350K Buy
+8,547
New +$370K ﹤0.01% 2653

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

AllianceBernstein's NVAX Position: Q2 2026 in Review

AllianceBernstein reduced its Novavax (NVAX) stake by 1.6% in Q2 2026, selling an estimated $23.4K and leaving 160,603 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2264.

AllianceBernstein first reported a position in NVAX in Q2 2013 and has held it in 53 quarters since. The position peaked at $19.3M in Q1 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • AllianceBernstein held 160,603 shares of Novavax worth $1.31M as of Q2 2026.
  • AllianceBernstein sold 2,610 Novavax shares in Q2 2026, an estimated $23.4K.
  • Novavax made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2264 holding.
  • AllianceBernstein first reported a position in Novavax in Q2 2013 and has held it in 53 quarters since.
  • AllianceBernstein's Novavax position peaked at $19.3M in Q1 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.